These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38038778)

  • 1. HIV Pre-exposure Prophylaxis (PrEP) Care in Belgium: A mixed-methods Study on PrEP Users' Experiences and Service Delivery Preferences.
    Rotsaert A; Vanhamel J; Vanbaelen T; Vuylsteke B; van der Loeff MS; Hensen B; Kielmann K; Callens S; Reyniers T
    AIDS Behav; 2024 Feb; 28(2):393-407. PubMed ID: 38038778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Exposure Prophylaxis Users' Attitudes About Sexually Transmitted Infections and Its Influence on Condom Use: A Mixed-Method Study in Belgium.
    Rotsaert A; Nöstlinger C; Van Landeghem E; Vanbaelen T; Wouters E; Buffel V; Scheerder G; Schim van der Loeff M; Vuylsteke B; Reyniers T
    AIDS Patient Care STDS; 2022 Dec; 36(12):483-492. PubMed ID: 36484763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
    Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
    J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP user profiles, dynamics of PrEP use and follow-up: a cohort analysis at a Belgian HIV centre (2017-2020).
    Rotsaert A; Reyniers T; Jacobs BKM; Vanbaelen T; Burm C; Kenyon C; Vuylsteke B; Florence E
    J Int AIDS Soc; 2022 Jul; 25(7):e25953. PubMed ID: 35773979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.
    Sales JM; Cwiak C; Haddad LB; Phillips A; Powell L; Tamler I; Sheth AN
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):414-418. PubMed ID: 30985558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of PrEP and condom use among PrEP users in Belgium: a web-based longitudinal study.
    Rotsaert A; Smekens T; Vuylsteke B; van der Loeff MS; Hensen B; Nöstlinger C; Wouters E; Vanhamel J; Scheerder G; Reyniers T
    BMC Public Health; 2023 May; 23(1):970. PubMed ID: 37237375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of PrEP on a STI clinic in a Belgian context: a provider's perspective.
    Apers L; Vanhamel J; Caluwaerts S; Platteau T; Kenyon C; Florence E
    Acta Clin Belg; 2021 Dec; 76(6):477-481. PubMed ID: 32468957
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
    BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium.
    Vanbaelen T; Rotsaert A; Jacobs BKM; Florence E; Kenyon C; Vuylsteke B; Laga M; Thijs R
    AIDS Patient Care STDS; 2022 Apr; 36(4):159-167. PubMed ID: 35438524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK.
    O'Halloran C; Croxford S; Mohammed H; Gill ON; Hughes G; Fifer H; Allen H; Owen G; Nutland W; Delpech V; Saunders JM
    Sex Transm Infect; 2021 Sep; 97(6):429-433. PubMed ID: 33082235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing disparities in Pre-exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida.
    Butts SA; Young B; Blackmon J; Doblecki-Lewis S
    BMC Health Serv Res; 2023 Nov; 23(1):1311. PubMed ID: 38012701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Enough: A Qualitative Study of Client Experience With Internet-Based Access to Pre-exposure Prophylaxis.
    Hughes SD; Koester KA; Engesaeth E; Hawkins MV; Grant RM
    J Med Internet Res; 2021 Jul; 23(7):e22650. PubMed ID: 36256828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
    Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
    J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.